Such a well run company. We expected the expenses to increase with the ramp up of NNZ-2591 but it's just unreal our net FX gain for the quarter has covered our entire R&D spend over that same period. Another thing to note, it is good to see that the staff & general corporate expenses remaining reasonable (as a %) compared to our R&D spend which is a good sign.
Ann: Q3 2023 quarterly activity and cash flow report, page-10
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |